| Cigna EviCore | MOL.CU.119.A: Preimplantation Genetic Screening and Diagnosis | 2026-01-01 |
| Cigna EviCore | MOL.CU.246.A: Hereditary (Germline) Testing After Tumor (Somatic) Testing | 2026-01-01 |
| Cigna EviCore | MOL.CU.256.A: Confirmatory Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.CU.291.A: Genetic Testing for Known Familial Mutations | 2026-01-01 |
| Cigna EviCore | MOL.CU.292.A: Genetic Testing for Variants of Uncertain Clinical Significance | 2026-01-01 |
| Cigna EviCore | MOL.CU.333.B: Medically Necessary Laboratory Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.124.A: Alpha-1 Antitrypsin Deficiency Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.125.A: Amyotrophic Lateral Sclerosis (ALS) Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.126.A: Angelman Syndrome Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.144.A: CADASIL Genetic Testing | 2026-01-01 |